BioMet
Bridgend
About BioMet
Biomet, Inc., together with its subsidiaries, engages in the design, manufacture, and marketing of surgical and non-surgical products primarily used by orthopedic surgeons and other musculoskeletal medical specialists in the United States, Europe, and internationally. The company’s reconstructive products include knee, hip, shoulders, and extremity joint replacement systems, as well as dental reconstructive implants, bone cements, and accessories; autologous therapy products; and the procedure-specific instrumentation required to implant the company’s reconstructive systems. It also offers various fixation devices comprising internal and external fixation devices, craniomaxillofacial fixation systems, and electrical stimulation devices. In addition, the company supplies spinal products, which include electrical stimulation devices addressing the spine, spinal fixation systems, and orthobiologics for the spine. Further, it offers sports medicine products, softgoods and bracing products, casting materials, general surgical instruments, operating room supplies, and other surgical products. The company was founded in 1977 and is headquartered in Warsaw, Indiana. Biomet, Inc. is a subsidiary of LVB Acquisition, Inc.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Website: biomet.co.ukhome-uk
- Phone: +44 (0) 1656 655221
Social Profiles
Canonical: https://fsome.com/organization/biomet-2998871 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.